Researchers are still working to determine the optimal dose for addiction applications (which may differ from metabolic dosing), identify which patient subpopulations respond best, understand whether benefits persist after discontinuation, and characterize any unique risks of using these medications in populations with active substance use disorders
$834.00 *NOT AVAILABLE to AL, ID, AK, HI This past June, the US Food and Drug Administration approved GLP-1, a glucagon-like peptide 1 receptor agonist, for chronic weight management, based on results from the four 68-week STEP (Treatment Effect in People with obesity) trials
Readers are advised to independently verify any critical information before acting upon it
Originally FDA-approved as an acne treatment in 1971, tretinoin was found to also improve signs of photoaging, such as wrinkles, brown spots and skin laxity
Layering Acids Safely: Using Salicylic Acid with AHAs Without Damaging Your Skin Barrier Chemical exfoliation has transformed modern skincare, offering smoother texture, brighter tone, and clearer pores when used correctly
GHK-Cu produced measurable collagen improvement in 70% of participants